These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 8886398

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices.
    Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG.
    Br J Pharmacol; 1996 Feb; 117(4):689-97. PubMed ID: 8646415
    [Abstract] [Full Text] [Related]

  • 3. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D, Dezso P, Boros A, Kolok S, Fodor L, Nagy J, Szombathelyi Z.
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.
    Avenet P, Léonardon J, Besnard F, Graham D, Depoortere H, Scatton B.
    Neurosci Lett; 1997 Feb 21; 223(2):133-6. PubMed ID: 9089691
    [Abstract] [Full Text] [Related]

  • 6. Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.
    Parsons CG, Danysz W, Bartmann A, Spielmanns P, Frankiewicz T, Hesselink M, Eilbacher B, Quack G.
    Neuropharmacology; 1999 Jan 21; 38(1):85-108. PubMed ID: 10193901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells.
    Priestley T, Laughton P, Myers J, Le Bourdellés B, Kerby J, Whiting PJ.
    Mol Pharmacol; 1995 Nov 21; 48(5):841-8. PubMed ID: 7476914
    [Abstract] [Full Text] [Related]

  • 9. Trapping channel block of NMDA-activated responses by amantadine and memantine.
    Blanpied TA, Boeckman FA, Aizenman E, Johnson JW.
    J Neurophysiol; 1997 Jan 21; 77(1):309-23. PubMed ID: 9120573
    [Abstract] [Full Text] [Related]

  • 10. Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors.
    Gilling KE, Jatzke C, Hechenberger M, Parsons CG.
    Neuropharmacology; 2009 Apr 21; 56(5):866-75. PubMed ID: 19371579
    [Abstract] [Full Text] [Related]

  • 11. Subtype-dependence of NMDA receptor channel open probability.
    Chen N, Luo T, Raymond LA.
    J Neurosci; 1999 Aug 15; 19(16):6844-54. PubMed ID: 10436042
    [Abstract] [Full Text] [Related]

  • 12. The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801.
    Rammes G, Mahal B, Putzke J, Parsons C, Spielmanns P, Pestel E, Spanagel R, Zieglgänsberger W, Schadrack J.
    Neuropharmacology; 2001 May 15; 40(6):749-60. PubMed ID: 11369029
    [Abstract] [Full Text] [Related]

  • 13. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
    Becker J, Li Z, Noe CR.
    Eur J Biochem; 1998 Sep 01; 256(2):427-35. PubMed ID: 9760184
    [Abstract] [Full Text] [Related]

  • 14. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC, Prorok M, Galdzicki Z, Castellino FJ.
    J Biol Chem; 2001 Jul 20; 276(29):26860-7. PubMed ID: 11335724
    [Abstract] [Full Text] [Related]

  • 15. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA, Reynolds IJ.
    J Pharmacol Exp Ther; 1999 May 20; 289(2):1041-7. PubMed ID: 10215685
    [Abstract] [Full Text] [Related]

  • 16. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T, Mirshahi T, Chandler LJ, Woodward JJ.
    J Neurochem; 1997 Dec 20; 69(6):2345-54. PubMed ID: 9375665
    [Abstract] [Full Text] [Related]

  • 17. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J, Kim C, Yeom HD, Nguyen KVA, Eom S, Lee S, Jung JH, Lee JH, Kim SH, Kim IK, Lee JH.
    Pharmacol Rep; 2020 Apr 20; 72(2):472-480. PubMed ID: 32048268
    [Abstract] [Full Text] [Related]

  • 18. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.
    Harty TP, Rogawski MA.
    Epilepsy Res; 2000 Mar 20; 39(1):47-55. PubMed ID: 10690753
    [Abstract] [Full Text] [Related]

  • 19. Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.
    Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY, Krishtal OA.
    Eur J Neurosci; 1996 Mar 20; 8(3):446-54. PubMed ID: 8963435
    [Abstract] [Full Text] [Related]

  • 20. Patch clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan).
    Parsons CG, Gruner R, Rozental J, Millar J, Lodge D.
    Neuropharmacology; 1993 Dec 20; 32(12):1337-50. PubMed ID: 8152525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.